RedChip Money Report
Recent Posts
- Supreme Court Ruling Opens New Markets for Cancer Genetics 06/14/2013
- MusclePharm Continues Rapid Global Expansion 06/11/2013
- GlyEco Achieves Important Milestone with Its Glycol Recycling Technology 06/06/2013
- Why Interest is Growing in Cancer Genetics 05/23/2013
- Lattice CEO Interviewed by The Wall Street Analyst 05/22/2013
- Lattice Sells Government Services Assets 05/10/2013
- Profire Energy Issues Guidance for Fiscal 2014 05/07/2013
- Why did billionaire investor John Pappajohn invest $12 million in Cancer Genetics? 05/07/2013
- Northwest Bio CEO Interviewed on Floor of New York Stock Exchange 05/06/2013
- MusclePharm: Major Global Expansion Underway 05/02/2013
Author Archives: Paul
Why did billionaire investor John Pappajohn invest $12 million in Cancer Genetics?
The Human Genome Project has spawned a new generation of biotechs focused on diagnosing and treating cancer using genetic data in ways that allow scientists, laboratories, clinics, and hospitals to pinpoint the various subtypes of cancer more… Read more
